# $FRANK Catalyst Posts & Social Intelligence Recap — April 20, 2026

> **Asset:** $FRANK  
> **Date:** 2026-04-20 (April 20, 2026)  
> **Canonical URL:** https://cryptitalk.com/tokens/frank/2026-04-20  
> **Token Profile:** https://cryptitalk.com/tokens/frank.md  
> **Market Rankings:** https://cryptitalk.com/rankings.md  

---



## Curated Viral Posts & Community Evidence


### Post #1 by @CoinMarketCap:blockonomi
> **Author:** ([@CoinMarketCap:blockonomi](https://x.com/CoinMarketCap:blockonomi))  
> **Metrics:** 0 likes · 0 retweets · 0 comments  

> **Posted:** 2026-04-20T12:05:10.198209+00:00  


> **Source Link:** [https://coinmarketcap.com/community/articles/69e61416c7af2d69d924f850/](https://coinmarketcap.com/community/articles/69e61416c7af2d69d924f850/)  


> 
> "AstraZeneca (AZN) Stock: Tozorakimab Achieves Phase III COPD Success in MIRANDA Study


TLDR Tozorakimab achieved its primary goal in AstraZeneca’s Phase III MIRANDA study for chronic obstructive pulmonary disease The investigational therapy demonstrated significant reduction in"




---

*Generated by Context Pilot Social Intelligence Engine.*